An EFS to Evaluate the Safety and Preliminary Effectiveness of the CGuard Prime™ Carotid Stent Placement in the Procedure Setting of Acute Ischemic Stroke.
Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The Jacobs Institute is conducting a Sponsor Investigator study of patients ≥ 18 years to establish safety and preliminary effectiveness in treating extracranial stenosis with the CGuard Prime™ Carotid Stent in the setting as an acute ischemic stroke.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 90
Healthy Volunteers: f
View:
• Patients ≥18-year-old; Carotid stenosis with at least ≥ 50% stenosis; National Institute of Health Stroke Scale (NIHSS) \>/=6; and evidence of large vessel occlusion (LVO) in the anterior circulation (i.e., intracranial internal carotid artery, M1 and proximal M2) by computed tomography angiography (CTA).
Locations
United States
New York
Jacobs Institute
RECRUITING
Buffalo
Contact Information
Primary
CARLOS LOUIS PENA, PhD
cpena@jacobsinstitute.org
2404810824
Time Frame
Start Date: 2025-01-01
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 15
Treatments
Experimental: C Guard Arm
Related Therapeutic Areas
Sponsors
Leads: Jacobs institute